Hèctor Corominas (Héctor Corominas, Hector Corominas)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Venues

Journal of clinical medicine

RMD open

Journal of personalized medicine

Medicina (Kaunas, Lithuania)

Hospital de la Santa Creu i Sant Pau

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de la Santa Creu i Sant Pau Jan 08 2018

Spain

Director :: Rheumatology Department

Universitat Autònoma de Barcelona (UAB). Facultat de Medicina Jan 08 2018

Spain

Associate Professor :: Medicine

Publications

Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
David Lobo-Prat, Luis Sainz, Ana Laiz, Anna De Dios, Lalis Fontcuberta, Susana Fernández, Montserrat Masip, Pau Riera, Neus Pagès-Puigdemont, Sandra Ros, Mar Gomis-Pastor, Hèctor Corominas
Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach. Journal of evaluation in clinical practice (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Lucía Vallez-Valero, Ingrid Gasó-Gago, Ángel Marcos Fendian, Gemma Garrido-Alejos, Adrià Riera-Magallón, Adrián Plaza Diaz, Cristina Martinez-Molina, Maria Antonia Mangues, Hèctor Corominas
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. Clinical rheumatology (2023)
María Angels Ortiz, Cesar Diaz-Torné, Juan Jose De Agustin, Paula Estrada, Delia Reina, María Victoria Hernandez, Hye Sang, Carlos Zamora, Elisabet Cantó, Hèctor Corominas, Silvia Vidal
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules 14 (1) (2023)
Jesús Tornero Molina, Blanca Hernández Cruz, Hèctor Corominas
Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of clinical medicine 13 (1) (2023)
María Angels Ortiz, Cesar Diaz-Torné, Juan Jose De Agustin, Paula Estrada, Delia Reina, María Victoria Hernandez, Hye Sang, Carlos Zamora, Elisabet Cantó, Hèctor Corominas, Silvia Vidal
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules 14 (1) (2023)
Raimon Sanmartí, Hèctor Corominas
Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of clinical medicine 12 (5) (2023)
Jesús Tornero Molina, Blanca Hernández Cruz, Hèctor Corominas
Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of clinical medicine 13 (1) (2023)
Hèctor Corominas, David Young, J R Fraser Cummings, Yoram Bouhnik, Alessandro Armuzzi, Diamant Thaci, Jihyun Kim
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. Clinical drug investigation (2023)
Raimon Sanmartí, Hèctor Corominas
Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of clinical medicine 12 (5) (2023)
María Angels Ortiz, Cesar Diaz-Torné, Juan Jose De Agustin, Paula Estrada, Delia Reina, María Victoria Hernandez, Hye Sang, Carlos Zamora, Elisabet Cantó, Hèctor Corominas, Silvia Vidal
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules 14 (1) (2023)
María Angels Ortiz, Cesar Diaz-Torné, Juan Jose De Agustin, Paula Estrada, Delia Reina, María Victoria Hernandez, Hye Sang, Carlos Zamora, Elisabet Cantó, Hèctor Corominas, Silvia Vidal
Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules 14 (1) (2023)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics 14 (9) (2022)
Anais Mariscal, Carlos Zamora, Cesar Diaz-Torné, María Angels Ortiz, Juan José de Agustín, Delia Reina, Paula Estrada, Patricia Moya, Hèctor Corominas, Sílvia Vidal
Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage. International journal of molecular sciences 23 (10) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of personalized medicine 13 (1) (2022)
Jessica D Murillo-Saich, Cesar Diaz-Torné, María Angels Ortiz, Roxana Coras, Paulo Vinicius Gil Alabarse, Anders Bay Nord, Hèctor Corominas, Silvia Vidal, Mónica Guma
Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study. Metabolomics : Official journal of the Metabolomic Society 17 (9) (2021)
Berta Magallares, David Lobo-Prat, Ivan Castellvi, Patricia Moya, Ignasi Gich, Laura Martinez-Martinez, Hye Sang Park, Ana Milena Millán, Ana Laiz, Cesar Diaz-Torné, Susana Fernandez, Hèctor Corominas
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease. Journal of clinical medicine 10 (11) (2021)
Cesar Diaz-Torné, M Angels Ortiz, Andrea Garcia-Guillen, Sicylle Jeria-Navarro, Lluís Sainz, Susana Fernandez-Sanchez, Hèctor Corominas, Silvia Vidal
The inflammatory role of silent urate crystal deposition in intercritical gout. Rheumatology (Oxford, England) 60 (11) (2021)
Anais Mariscal, Carlos Zamora, Berta Magallares, Tarek Carlos Salman Monte, María Angels Ortiz, Cesar Díaz-Torné, Iván Castellví, Hèctor Corominas, Silvia Vidal
Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE. International journal of molecular sciences 22 (9) (2021)
Patricia Moya, Alejandro Fernandez Leon, Maria Emilia Corica, Valle Camacho Marti, Diego Alfonso López-Mora, Ivan Castellvi, Hèctor Corominas
"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica". PloS one 16 (9) (2021)
Hèctor Corominas, Ivan Castellvi, Pere Domingo, Jordi Casademont
Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists. European journal of rheumatology 7 (Suppl 2) (2020)
Ivan Castellvi, Carmen Pilar Simeón, Monica Sarmiento, Jordi Casademont, Hèctor Corominas, Vicenç Fonollosa
Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers. PloS one 15 (12) (2020)
Tarek Carlos Salman Monte, Carlos Sánchez-Piedra, Monica Fernandez Castro, Jose Luis Andreu, Víctor M Martínez-Taboada, Alejandro Olivé, José Rosas, Raúl Menor, Beatriz Rodríguez, Ángel García-Aparicio, Francisco Javier Lopez Longo, Sara Manrique Arija, Jesus Alberto Garcia Vadillo, Susana Gil Barato, Ruth López-González, Carlos Galisteo, Jorge Gonzalez Martin, Esther Ruiz Lucea, Celia Erausquin, Sheila Melchor, Begoña Moreira, Enrique Raya Álvarez, Jose María Pego-Reigosa, Natalia Cid, Enrique Júdez, Clara Moriano, Francisco Javier Narváez, Hèctor Corominas, Blanca Garcia Magallon, Carlos A Guillén-Astete, Ivan Castellvi, Cristina Bohórquez, Javier Loricera, Joaquín Belzunegui, Óscar Illera, Vicenç Torrente-Segarra
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome. Rheumatology international 40 (8) (2020)
Cesar Diaz-Torné, María Angels Ortiz, Mónica Sarmiento, César Díaz-López, Hèctor Corominas, Jordi Casademont, Silvia Vidal
Rituximab levels are associated with the B cell homeostasis but not with the clinical response in patients with rheumatoid arthritis. European journal of rheumatology 6 (2) (2019)
Delia Reina Sanz, Hèctor Corominas
Visceral Leishmaniasis in the Mediterranean area. European journal of rheumatology 5 (1) (2017)

Hèctor Corominas.css-eqlu8i{font-size:small;padding-left:4px;} (Héctor Corominas, Hector Corominas)

Publication Activity (10 Years)

Top Topics

Top Venues

Hèctor Corominas (Héctor Corominas, Hector Corominas)